Navneet Bung

<i>De Novo</i> Design of New Chemical Entities for SARS-CoV-2 Using Artificial Intelligence

Navneet Bung, Sowmya Ramaswamy Krishnan, Gopalakrishnan Bulusu et al. · Future Medicinal Chemistry · 2021 · 105 citations · Full text

Pharmacy, Bioinformatics, Medicinal Chemistry +17

Accelerating <i>De Novo</i> Drug Design against Novel Proteins Using Deep Learning

Sowmya Ramaswamy Krishnan, Navneet Bung, Gopalakrishnan Bulusu et al. · Journal of Chemical Information and Modeling · 2021 · 89 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

A novel SIRT1 inhibitor, 4bb induces apoptosis in HCT116 human colon carcinoma cells partially by activating p53

Ananga Ghosh, Amrita Sengupta, Guru Pavan Kumar Seerapu et al. · Biochemical and Biophysical Research Communications · 2017 · 47 citations

Medicine, Cancer Biology, Oncology +16

Human hydroxymethylbilane synthase: Molecular dynamics of the pyrrole chain elongation identifies step-specific residues that cause AIP

Navneet Bung, Arijit Roy, Brenden Chen et al. · Proceedings of the National Academy of Sciences · 2018 · 35 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +6

De Novo Design of New Chemical Entities (NCEs) for SARS-CoV-2 Using Artificial Intelligence

Navneet Bung, Sowmya Ramaswamy Krishnan, Gopalakrishnan Bulusu et al. · ChemRxiv · 2020 · 23 citations · Full text

Pharmacy, Medicinal Chemistry, Molecular Biology +17